Zurcher Kantonalbank (Zurich Cantonalbank) - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 86 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,171
-5.8%
20,317
+42.6%
0.00%0.0%
Q2 2023$147,700
+87.1%
14,243
+45.9%
0.00%
Q1 2023$78,950
-48.6%
9,7590.0%0.00%
-100.0%
Q4 2022$153,704
+30.3%
9,759
+30.1%
0.00%0.0%
Q3 2022$118,000
+12.4%
7,5010.0%0.00%0.0%
Q2 2022$105,000
-18.6%
7,5010.0%0.00%0.0%
Q1 2022$129,000
+18.3%
7,5010.0%0.00%0.0%
Q4 2021$109,000
+87.9%
7,501
+133.6%
0.00%
Q3 2021$58,000
+427.3%
3,211
+76.6%
0.00%
Q1 2019$11,000
-15.4%
1,8180.0%0.00%
Q4 2018$13,000
-50.0%
1,8180.0%0.00%
Q3 2018$26,000
-27.8%
1,8180.0%0.00%
Q2 2018$36,000
+12.5%
1,8180.0%0.00%
Q1 2018$32,000
-28.9%
1,8180.0%0.00%
Q4 2017$45,000
+32.4%
1,818
+39.7%
0.00%
Q3 2017$34,000
-2.9%
1,3010.0%0.00%
Q2 2017$35,000
-75.5%
1,301
-72.9%
0.00%
-100.0%
Q1 2017$143,000
+308.6%
4,801
+269.0%
0.00%
Q4 2016$35,0001,3010.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders